• Home
  • Academics
  • Student
  • Faculty
  • Community
  • Alumni
  • Opportunities

The Pipette Gazette

0 Comment

Pancreatic Cancer From Mouse To Man: Medicine’s Next Big Thing?

24 Jul 2018
anthonyc

Dr. Bruno Doiron was featured in the Ivanhoe News article, ”
Pancreatic Cancer From Mouse To Man,” for his work with pancreatic cancer. Dr. Doiron is developing a new technology that allows pancreatic tumors in mice to develop with the same traits as human pancreatic cancer.

“I use the mutation found in pancreatic cancer found in humans so that mimics more randomly what’s happening in the cancer development.” Doiron said.

Doiron injects a modified virus into the mouse. That virus delivers two human cancer genetic mutations into the mouse pancreas. The human-like cancers that develop give researchers an effective way to test new drugs. It’s a finding that’s applauded by patients like Davila.

“Without that how can we find a treatment for the cancer that we have.” Davila said.

A U.S. patent is pending on the gene delivery technology developed by Doiron.

Social Share

  • google-share

Filter by categories

  • Academics
  • All Blogs
  • Alumni
  • Alumni News
  • Beyond The Bench
  • Career Development
  • Career Series
  • Community
  • Faculty
  • Faculty Spotlight
  • Final Words…
  • In Press
  • Incoming Student Spotlight
  • Meet The Researcher
  • Opportunities & Upcoming Events
  • Student
  • Student News
  • Words of Wisdom

Recent Posts

  • From Discovery to Diagnosis: How UT San Antonio Researchers Are Transforming Endometriosis Care
  • Esteban Castro Reflects on BIO International Conference and SMDP Scholar Journey
  • GSBS Students Showcase the Future of Biotech at Nucleate Texas Demo Day
  • Wasmuth named Howard Hughes Medical Institute Freeman Hrabowski Scholar
  • Candidacy Ceremony Means More Than a New White Coat